Publication: Some N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted)ureido/thioureido]benzenesulfonamides as carbonic anhydrase I and II Inhibitors
dc.contributor.author | KAYMAKÇIOĞLU, BEDİA | |
dc.contributor.authors | Turk, Sevda; Tok, Fatih; Celik, Hulya; Karakus, Sevgi; Nadaroglu, Hayrunnisa; Kocyigit-Kaymakcioglu, Bedia; Kucukoglu, Kaan | |
dc.date.accessioned | 2022-03-14T08:27:18Z | |
dc.date.available | 2022-03-14T08:27:18Z | |
dc.date.issued | 2016-08-25 | |
dc.description.abstract | In the present study, N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted)ureido]benzenesulfonamide (1-9) and N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted) thioureido]benzenesulfonamide (10-14) derivatives were synthesized from 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl) benzenesulfonamide (sulfamethizole). All new compounds were characterized by elemental analysis and various spectroscopic methods (FTIR, H-1-NMR and MS). These new sulfonamide derivatives were investigated as inhibitors of carbonic anhydrase especially human carbonic anhydrase I and II. The new compounds showed higher activity against the human cytosolic CA I (IC50 values 0.144-15.65 nM) and CA II (IC50 values 0.109-17.95 nM) in comparison with the clinically used CA inhibitor acetazolamide. | |
dc.identifier.doi | 10.12991/marupj.259885 | |
dc.identifier.issn | 1309-0801 | |
dc.identifier.uri | https://hdl.handle.net/11424/241811 | |
dc.identifier.wos | WOS:000391177500011 | |
dc.language.iso | eng | |
dc.publisher | MARMARA UNIV, FAC PHARMACY | |
dc.relation.ispartof | MARMARA PHARMACEUTICAL JOURNAL | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Carbonic anhydrase inhibitors | |
dc.subject | sulfonamide | |
dc.subject | sulfamethizole | |
dc.subject | urea and thiourea | |
dc.subject | PURIFICATION | |
dc.subject | XII | |
dc.title | Some N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted)ureido/thioureido]benzenesulfonamides as carbonic anhydrase I and II Inhibitors | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | a2a6ad12-5c2a-4a37-8e32-dce27fb54ad9 | |
local.import.package | SS16 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.journal.numberofpages | 7 | |
oaire.citation.endPage | 95 | |
oaire.citation.issue | 1 | |
oaire.citation.startPage | 89 | |
oaire.citation.title | MARMARA PHARMACEUTICAL JOURNAL | |
oaire.citation.volume | 21 | |
relation.isAuthorOfPublication | 0f8e7ba6-02e7-4232-84bb-31777a356761 | |
relation.isAuthorOfPublication.latestForDiscovery | 0f8e7ba6-02e7-4232-84bb-31777a356761 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Türk et al. - 2016 - Some N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-subs.pdf
- Size:
- 118.22 KB
- Format:
- Adobe Portable Document Format